4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-007356
Chief Executive Officer acquired 20,254 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carpenter George C IV Chief Executive Officer | 2016-09-21 | Option exercise | +20,254 | $5.00 | $101,270 | 32,208 | D |
| Derivatives | |||||||
| Carpenter George C IV Chief Executive Officer | 2016-09-21 | Option exercise · 5% Secured Convertible Note due December 2017 | −0 | D | |||
| Carpenter George C IV Chief Executive Officer | 2016-09-21 | Returned to the company · Common Stock Warrant | −0 | 0 | D | ||
Loading xslF345X03/s104193_form4.xml…